Insider · CIK 0001883139
School Of Medicine At Mount Sinai Icahn
Files at RNLXY (Renalytix plc), WGS (GeneDx Holdings Corp.). First filing Nov 4, 2024, latest Nov 19, 2024.
School Of Medicine At Mount Sinai Icahn files SEC Form 4 as 10% owner at WGS (GeneDx Holdings Corp.), and also at RNLXY (Renalytix plc). Since Nov 4, 2024, School Of Medicine At Mount Sinai Icahn has reported 0 open-market buys worth $0 and 2 open-market sells worth $75M, the latest filed on Nov 19, 2024.
A track record needs three past buys with six months of prices behind them; School Of Medicine At Mount Sinai Icahn has 0, so none is measured yet.
The newest scored trade: sold $10M of WGS on Nov 15, 2024, filed Nov 19, 2024, scored 52 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
WGS: GeneDx Holdings Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | GeneDx Holdings Corp. | $10M 147,141 shares | -5% | - | |
| 57Moderate | GeneDx Holdings Corp. | $65M 865,800 shares | -23% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 14, 2025 | WGS GeneDx Holdings Corp. | 250,000 0.89% of outstanding | $25M | Apr 14, 2025 | $120M |
| Feb 24, 2025 | WGS GeneDx Holdings Corp. | 373,569 1.33% of outstanding | $36M | Feb 24, 2025 | $131M |
| Jan 30, 2025 | WGS GeneDx Holdings Corp. | 1,346,123 4.90% of outstanding | $105M | Jan 30, 2025 | $75M |
| Oct 31, 2024 | WGS GeneDx Holdings Corp. | 1,012,941 3.69% of outstanding | $83M | Oct 31, 2024 | none |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 15, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -20,359 | $69.78 | $1.4M | 2,846,474 | Nov 19, 2024 |
| Nov 18, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -126,782 | $70.78 | $9.0M | 2,719,692 | Nov 19, 2024 |
| Nov 1, 2024 | RNLXY Renalytix plc | JOther Ordinary Shares | +13,366,750 | $0.12 | $1.6M | 32,683,998 | Nov 5, 2024 |
| Oct 31, 2024 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -865,800 | $75.00 | $65M | 2,866,833 | Nov 4, 2024 |
Questions about School Of Medicine At Mount Sinai Icahn
Answered from the filings on this page, as of the latest one.
Is School Of Medicine At Mount Sinai Icahn buying or selling?
Not in the last 12 months. School Of Medicine At Mount Sinai Icahn's latest open-market trade on SEC Form 4 was sold $10M of WGS on Nov 15, 2024.
How did School Of Medicine At Mount Sinai Icahn's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and School Of Medicine At Mount Sinai Icahn has 0.
Where does School Of Medicine At Mount Sinai Icahn file Form 4?
School Of Medicine At Mount Sinai Icahn has filed Form 4 at WGS (GeneDx Holdings Corp.); RNLXY (Renalytix plc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.